-
Researchers Pursue a Targeted Treatment for Colitis-Causing Bacteria
Current antibiotic treatments for Clostridioides difficile infection (CDI), which causes the chronic, degenerative disease colitis, eliminate beneficial bacteria in the gut along with the harmful... Read more
-
Reassessing Mandatory Mastectomy Recommendations
New guidelines on how to treat hereditary breast cancer could be a gamechanger. Read more
-
Case Studies: Direct Primary Care Pioneers
Direct primary care (DPC) offers physicians and patients an alternative to fee-for-service care involving third-party payers. Two physicians who have been immersed in DPC for years say it has allowed... Read more
That’s News
A New Combination Therapy for HER2-Positive Metastatic Breast Cancer
The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine...
Researchers: Risk-Takers Needed to Fuel R&D
Individuals who are inclined to take risks are more likely to make decisions that lead to innovation, a key factor that companies should consider as they seek to jumpstart research and development — and economic growth — in the wake of the COVID-19 virus.
Coding for Virtual Visits
New CMS rules and waivers expanding the use of telemedicine in response to the COVID-19 pandemic have left providers with questions about coding and billing.
Case Studies: Direct Primary Care Pioneers
Direct primary care (DPC) offers physicians and patients an alternative to fee-for-service care involving third-party payers. Two physicians who have been immersed in DPC for years say it has allowed them to get back to the basics of medicine — and that patients’ response proves it is a force to be reckoned with.
New Drug Therapy Shows Promise for Cystic Fibrosis
An FDA-approved drug cocktail may provide improvement for many patients with this common hereditary disease.
- ‹ previous
- 2 of 236
- next ›